Characterization of recombinant and natural forms of the human LIM domain-containing protein FHL2

被引:10
|
作者
El Mourabit, H
Müller, S
Tunggal, L
Paulsson, M
Aumailley, M
机构
[1] Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany
[2] Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany
关键词
FHL2; LIM domain; baculovirus; MALDI-TOF; mass spectrometry;
D O I
10.1016/S1046-5928(03)00211-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
FHL2 (Four and a Half LIM domain-containing protein 2) is a member of a small family of proteins with four LIM domains and an N-terminal half LIM domain. It is an intracellular protein thought to function as an adaptor in the formation of multi-protein complexes involved in signaling. To obtain human FHL2 in amounts allowing further characterization, we evaluated different expression systems and chose to express FHL2 with a His6 tag in insect cells using the baculovirus system. The recombinant protein was highly expressed and could be purified to >98% homogeneity as judged by SDS-PAGE analysis. Purified recombinant FHL2 was used to generate antibodies allowing detection and immunoprecipitation of FHL2 from human cells. Both recombinant and natural FHL2 were characterized by SDS-PAGE and MALDI-TOF mass spectrometry. The molecular mass of the recombinant His6-tagged protein obtained by mass spectrometry was 36,995 Da, in good agreement with the apparent mass of 36 kDa in SDS-PAGE and slightly higher than the 35,981 Da calculated from the sequence of the construct. The measured molecular mass of natural human FHL2 was 32,742 Da and the calculated mass was 32,192 Da. However, the apparent molecular mass in SDS-PAGE is 41 kDa, indicating that the natural protein has an abnormal electrophoretic mobility. The results show that both the recombinant and the natural proteins are post-translationally modified and indicate that such modifications may lead to an abnormal electrophoretic behavior of natural human FHL2. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:95 / 103
页数:9
相关论文
共 50 条
  • [1] Analysis of the adaptor function of the LIM domain-containing protein FHL2 using an affinity chromatography approach
    El Mourabit, H
    Müller, S
    Tunggal, L
    Paulsson, M
    Aumailley, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (03) : 612 - 625
  • [2] Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart
    Chan, KK
    Tsui, SKW
    Lee, SMY
    Luk, SCW
    Liew, CC
    Fung, KP
    Waye, MMY
    Lee, CY
    GENE, 1998, 210 (02) : 345 - 350
  • [3] Identification of the LIM protein FHL2 as a coactivator of β-catenin
    Wei, Y
    Renard, CA
    Labalette, C
    Wu, YF
    Lévy, L
    Neuveut, C
    Prieur, X
    Flajolet, M
    Prigent, S
    Buendia, MA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (07) : 5188 - 5194
  • [4] Protein-protein interaction of FHL2, a LIM domain protein preferentially expressed in human heart, with hCDC47
    Chan, KK
    Tsui, SKW
    Ngai, SM
    Lee, SMY
    Kotaka, M
    Waye, MMY
    Lee, CY
    Fung, KP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, 76 (03) : 499 - 508
  • [5] Translocation of a human focal adhesion LIM-only protein, FHL2, during myofibrillogenesis and identification of LIM2 as the principal determinants of FHL2 focal adhesion localization
    Li, HY
    Kotaka, M
    Kostin, S
    Lee, SMY
    Kok, LDS
    Chan, KK
    Tsui, SKW
    Schaper, J
    Zimmermann, R
    Lee, CY
    Fung, KP
    Waye, MMY
    CELL MOTILITY AND THE CYTOSKELETON, 2001, 48 (01): : 11 - 23
  • [6] Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity
    Clemente-Olivo, P. Maria
    Habibe, J. Jayron
    Vos, Mariska
    Ottenhoff, Roelof
    Jongejan, Aldo
    Herrema, Hilde
    Zelcer, Noam
    Kooijman, Sander
    Rensen, Patrick C. N.
    Raalte, Daniel H. van
    Nieuwdorp, Max
    Eringa, Etto C.
    de Vries, J. Carlie
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 121
  • [7] Cardiac-enriched LIM domain protein fhl2 is required to generate IKs in a heterologous system
    Kupershmidt, S
    Yang, ICH
    Sutherland, M
    Wells, KS
    Yang, T
    Yang, P
    Balser, JR
    Roden, DM
    CARDIOVASCULAR RESEARCH, 2002, 56 (01) : 93 - 103
  • [8] How (Epi)Genetic Regulation of the LIM-Domain Protein FHL2 Impacts Multifactorial Disease
    Habibe, Jayron J.
    Clemente-Olivo, Maria P.
    de Vries, Carlie J.
    CELLS, 2021, 10 (10)
  • [9] Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation
    Lai, CF
    Bai, ST
    Uthgenannt, BA
    Halstead, LR
    McLoughlin, P
    Schafer, BW
    Chu, PH
    Chen, J
    Otey, CA
    Cao, X
    Cheng, SL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (01) : 17 - 28
  • [10] Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice
    Huss, Sebastian
    Stellmacher, Christian
    Goltz, Diane
    Khlistunova, Inna
    Adam, Alexander C.
    Trebicka, Jonel
    Kirfel, Jutta
    Buettner, Reinhard
    Weiskirchen, Ralf
    BMC GASTROENTEROLOGY, 2013, 13